Blood pressure, antihypertensive treatment, and graft survival in kidney transplant patients

Transplant International

Volumn 22, Issue 11, 2009, Pages 1073-1080

  Hillebrand, Uta ^a   Suwelack, Barbara M ^a   Loley, Karsten ^a   Lang, Detlef ^a   Reuter, Stefan ^a   Amler, Susanne ^a   Pavenstädt, Hermann ^a   Hausberg, Martin ^a   Büssemaker, Eckhart ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Angiotensin receptor blocker; Angiotensin converting enzyme inhibitor; Arterial hypertension; Calcium channel blocker; Graft survival; Renal transplantation

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DEATH; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HYPERTENSION; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; HYPERTENSION; KAPLAN-MEIERS ESTIMATE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; REOPERATION; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 70349686851     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2009.00922.x     Document Type: Article

References (37)

1. World Health Organization-International Society of Hypertension. Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999 17 : 151.
2. Opelz G, Wujciak T, Ritz E. Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study. Kidney Int 1998 53 : 217.
3. Jafar TH, Schmid CH, Landa M, et al. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med 2001 135 : 73.
4. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993 329 : 1456.
5. K/DOQI. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004 43 : S1.
6. Karthikeyan V, Karpinski J, Nair RC, Knoll G. The burden of chronic kidney disease in renal transplant recipients. Am J Transplant 2004 4 : 262.
7. Meier-Kriesche HU, Baliga R, Kaplan B. Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation. Transplantation 2003 75 : 1291.
8. Ortiz F, Paavonen T, Tornroth T, et al. Predictors of renal allograft histologic damage progression. J Am Soc Nephrol 2005 16 : 817.
9. Halloran PF. Call for revolution: a new approach to describing allograft deterioration. Am J Transplant 2002 2 : 195.
10. Seron D, Moreso F, Grinyo JM. Prevention and management of late renal allograft dysfunction. J Nephrol 2001 14 : 71.
11. Heinze G, Mitterbauer C, Regele H, et al. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol 2006 17 : 889.
12. Philipp T, Legendre C, Geiger H, et al. Study on the evaluation of candesartan cilexetil after renal transplantation (SECRET-Study). Dtsch Med Wochenschr 2004 129 (suppl. 3 S141.
13. Rahn KH, Barenbrock M, Fritschka E, et al. Effect of nitrendipine on renal function in renal-transplant patients treated with cyclosporin: a randomised trial. Lancet 1999 354 : 1415.
14. Mann JF, Schmieder RE, McQueen M, et al. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet 2008 372 : 547.
15. Opelz G, Zeier M, Laux G, et al. No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report. J Am Soc Nephrol 2006 17 : 3257.
16. Whitworth JA. World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003 21 : 1983.
17. Brenner BM, Cooper ME, de ZD, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001 345 : 861.
18. Nakao N, Yoshimura A, Morita H, et al. Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial. Lancet 2003 361 : 117.
19. Viberti G, Mogensen CE, Groop LC, Pauls JF. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group. JAMA 1994 271 : 275.
20. Curtis JJ, Laskow DA, Jones PA, et al. Captopril-induced fall in glomerular filtration rate in cyclosporine-treated hypertensive patients. J Am Soc Nephrol 1993 3 : 1570.
21. Mourad G, Ribstein J, Mimran A. Converting-enzyme inhibitor versus calcium antagonist in cyclosporine-treated renal transplants. Kidney Int 1993 43 : 419.
22. Sennesael J, Lamote J, Violet I, et al. Comparison of perindopril and amlodipine in cyclosporine-treated renal allograft recipients. Hypertension 1995 26 : 436.
23. van der Schaaf MR, Hene RJ, Floor M, et al. Hypertension after renal transplantation. Calcium channel or converting enzyme blockade? Hypertension 1995 25 : 77.
24. Heinze G, Oberbauer R. Does size matter? Nephrol Dial Transplant 2007 22 : 2725.
25. Ruggenenti P, Perna A, Gherardi G, et al. Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Lancet 1998 352 : 1252.
26. Halimi JM, Laouad I, Buchler M, et al. Early low-grade proteinuria: causes, short-term evolution and long-term consequences in renal transplantation. Am J Transplant 2005 5 : 2281.
27. Amer H, Fidler ME, Myslak M, et al. Proteinuria after kidney transplantation, relationship to allograft histology and survival. Am J Transplant 2007 7 : 2748.
28. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999 130 : 461.
29. Yusuf S, Teo KK, Pogue J, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008 358 : 1547.
30. Cosio FG, Pesavento TE, Kim S, et al. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int 2002 62 : 1440.
31. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003 3 : 178.
32. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on surival in end-stage renal disease. Circulation 1999 99 : 2434.
33. Covic A, Goldsmith DJ, Gusbeth-Tatomir P, Buhaescu I, Covic M. Successful renal transplantation decreases aortic stiffness and increases vascular reactivity in dialysis patients. Transplantation 2003 76 : 1573.
34. London GM, Blacher J, Pannier B, Guérin AP, Marchais SJ, Safar ME. Arterial wave reflections and survival in end-stage renal failure. Hypertension 2001 38 : 434.
35. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.13 Analysis of patient and graft survival. Nephrol Dial Transplant 2002 17 (Suppl 4 60.
36. Ekberg H, Tedesco-Silva H, Demirbas A, et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007 357 : 2562.
37. Burke GW III., Kaufman DB, Millis JM, et al. Prospective, randomized trial of the effect of antibody induction in simultaneous pancreas and kidney transplantation: three-year results. Transplantation 2004 77 : 1269.